These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3017107)

  • 1. Renovascular hypertension: treatment with the oral angiotensin-converting enzyme inhibitor enalapril.
    Jackson B; Murphy BF; Johnston CI; Kincaid-Smith P; Whitworth JA
    Am J Nephrol; 1986; 6(3):182-6. PubMed ID: 3017107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril (MK421) in the treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    J Hypertens Suppl; 1983 Oct; 1(1):109-17. PubMed ID: 6100599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential renal function during angiotensin converting enzyme inhibition in renovascular hypertension.
    Jackson B; McGrath BP; Matthews PG; Wong C; Johnston CI
    Hypertension; 1986 Aug; 8(8):650-4. PubMed ID: 3015794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enalapril in the treatment of renovascular hypertension.
    Knecht A; Grossman E; Rosenthal T
    Clin Exp Hypertens A; 1985; 7(10):1377-93. PubMed ID: 3000654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
    Franklin SS; Smith RD
    Am J Med; 1985 Sep; 79(3C):14-23. PubMed ID: 2996342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Murray GD; Robertson JI
    Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1697-9. PubMed ID: 6293638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of neonatal renovascular hypertension with intravenous enalapril.
    Mason T; Polak MJ; Pyles L; Mullett M; Swanke C
    Am J Perinatol; 1992 Jul; 9(4):254-7. PubMed ID: 1627214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
    Jackson B; Franze L; Sumithran E; Johnston CI
    J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with labetalol and enalapril in combination in patients with severe essential and renovascular hypertension.
    White WB; Aydelotte ME
    Am J Med Sci; 1988 Sep; 296(3):187-91. PubMed ID: 2845781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension.
    Franklin SS; Smith RD
    Nephron; 1986; 44 Suppl 1():73-82. PubMed ID: 3018602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
    Wang YX; Gavras I; Wierzba T; Gavras H
    J Lab Clin Med; 1992 Mar; 119(3):267-72. PubMed ID: 1541876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril in the treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson I; Robertson JI
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1413-7. PubMed ID: 6315126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.
    Ferrier C; Ferrari P; Weidmann P; Keller U; Beretta-Piccoli C; Riesen WF
    Drugs; 1992; 44 Suppl 1():74-84. PubMed ID: 1283588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension.
    Karlberg BE; Rosenqvist U
    Acta Med Scand Suppl; 1986; 714():33-42. PubMed ID: 3033998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term monotherapy with lisinopril in renovascular hypertension.
    Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Junggren IL
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S61-5. PubMed ID: 2442555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure response of two types of Goldblatt hypertensive rats to enalapril.
    Wang H; Gu TH; Pan WH; Gong LS
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S119-21. PubMed ID: 2485044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical pharmacology of enalapril.
    Gomez HJ; Cirillo VJ; Jones KH
    J Hypertens Suppl; 1983 Oct; 1(1):65-70. PubMed ID: 6100610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.